- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
SMV expects clearance for PET/CT this summer
At this year’s Society of Nuclear Medicine meeting, imaging systems that fused PET with CT was a feature seen at a few vendor booths, including GE and SMV of Ohio. SMV displayed a combination PET/CT system called Positrace that was first seen at
At this years Society of Nuclear Medicine meeting, imaging systems that fused PET with CT was a feature seen at a few vendor booths, including GE and SMV of Ohio. SMV displayed a combination PET/CT system called Positrace that was first seen at last years RSNA meeting.
SMV anticipated that these two technologies belong together, said Lonnie Mixon, SMVs vice president of worldwide marketing.
The first Positrace system has been installed in France. SMV applied for a 510(k) for the system in May. It expects approval by the end of August.
The device uses specialized digital detectors in a hexagonal ring configuration with thick NaI crystals. Although the system looks like a single unit, the CT scanner is attached to the PET scanner on one end. The Positrace has a 50-cm axial view and a 70-cm patient aperture.
This reduces the claustrophobic sensation, Mixon said.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
